Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cethrin in Acute Cervical Spinal Cord Injury
NCT02053883Phase 3Withdrawn
- Sponsor
- BioAxone BioSciences
- Start
- Jul 2015
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of cethrin in spinal cord injury (SCI), sponsored by BioAxone BioSciences. Planned start Jul 2015; status: withdrawn.
02
Drugs
cethrin
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02053883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053883.